Cancer is one of the leading causes of mortality and disability worldwide. Although great advances in cancer treatments such as chemotherapy, surgery, and radiation are currently being achieved, their application is associated with numerous and expensive adverse side effects. Epidemiological evidence has demonstrated that the consumption of certain foods potentially prevents up to 35% of cancer cases. Bioactive components are ubiquitous in nature, also in dietary food, providing an essential link in health maintenance, promotion, and prevention of chronic diseases, such as cancer. Development of bioactive proteins and peptides is a current and innovative strategy for cancer prevention/cure. A growing body of anticancer protein and peptides from natural sources has shown the ability to reduce tumor progression through multiple mechanisms including apoptotic, antiproliferative, antiangiogenic, and immunomodulatory activities. This review is focused on proteins and peptides from different food sources including plants, milk, egg, and marine organisms in which chemopreventive properties have been demonstrated. Other aspects such as mechanism of action, bioavailability, and identification and characterization of food-derived peptides by advance separated technologies are also included. This review highlights the potential application of food-derived peptides as functional food ingredients and pharmaceutical candidates in the auxiliary therapy of cancer.
Diet and cancer
Cancer is one of the leading causes of mortality and disability worldwide, responsible for approximately 13% of deaths (Ferlay et al., 2010) . In the last decades, there have been great advances in cancer treatments such as chemotherapy, surgery, and radiation. However, these therapies are highly expensive and include drugs with numerous adverse side effects. Thus, there is a clear need for cheaper and more effective strategies to maximize cure rates with minimal toxicity. In addition, many researchers have focused on alternatives to prevent tumor, thus reducing the high rates of mortality and the elevated costs of therapies. It has been estimated that only 5-10% of all cancer cases are due to genetic defects whereas the remaining 90-95% are attributed to environmental and lifestyle factors (Anand et al., 2008) . Epidemiological evidence has demonstrated that modifications of nutritional factors and food consumption patterns can potentially prevent up to 35% of cancer cases (Marmot et al., 2007) , although the actual percentage depends on the dietary component and the specific type of cancer (Davis and Milner, 2007) .
Chemoprevention has been defined as "the use of natural and/or synthetic substances to block, reverse, or retard the process of carcinogenesis." Among chemopreventive agents, those present in foods have been demonstrated to exert antiproliferative activity, to lower cancer risk, and even to sensitize tumor cells against anticancer therapies (B eliveau and Gingras, 2007) . Extensive research has revealed that a diet consisting of fruits, vegetables, spices, and grains has the potential to prevent cancer. The bioactive substances contained in these plant species, including essential nutrients, polyunsaturated fatty acids, and phytochemicals, are responsible for the demonstrated cancer preventive effects, and thus, they have been extensively studied (Anand et al., 2008) . However, food bioactives are not limited to plants, since animal and fungi food products can also contain compounds with anticancer properties. Recently, the crucial role played by gut microbiota to release compounds with both pro-and anticancerigen effects has been recently reported (Milner, 2004) . Therefore, knowledge on the effect of dietary components on health will bring new opportunities for chemoprevention through intense alterations in dietary regimens.
Chemopreventive effects of food proteins and peptides
Currently, the development of proteins and peptides with useful anticancer potential is an innovative strategy for cancer prevention/cure Raucher et al., 2009) . They (mainly peptides) possess certain key advantages over alternative chemotherapy molecules, such as their high affinity, good penetration in tissues, strong specificity for targets, and low toxicity (Bhutia and Maiti, 2008) . A number of anticancer protein and peptides from natural sources have been reported. They have shown the ability to reduce tumor progression through multiple mechanisms including apoptotic, function-blocking, antiangiogenic, and immunomodulatory activities (Bhutia and Maiti, 2008) . Among them, those proteins and peptides derived from foods have become an interesting alternative because of their low price, nontoxic nature, less adverse side effects, and their high acceptance by consumers (Silva-S anchez et al., 2008) . It has been reported that these food peptides can act preventing the different stages of cancer, including initiation, promotion, and progression (de Mejia and Dia, 2010) . This review is focused on proteins and peptides from different food sources for which chemopreventive properties have been demonstrated by in vitro and in vivo studies. Other aspects such as mechanism of action, bioavailability, and clinical evidence of the effects of these components will also be included.
Anticancer plant proteins and peptides
In the last years, plant proteins and peptides with cytotoxic activity against cancer cells have become promising alternatives for the development of new anticancer drugs. The following section focused on those proteins and peptides with demonstrated anticarcinogenic properties.
Plant lectins
Plant lectins are proteins or glycoproteins of nonimmune origin widely distributed in seeds, roots, stems, and leaves (Moreira et al., 1991) . They contain at least one noncatalytic domain that enables them to selectively identify and reversibly bind to specific carbohydrates without altering their structure (Van Damme et al., 1998) . According to their carbohydrate-binding specificity, lectins are classified into 12 different families, such as (1) Agaricus bisporus agglutinin homologs, (2) Amaranthins, (3) Class V chitinase homologs with lectin activity, (4) Cyanovirin family, (5) Euonymus europaeus agglutinin family, (6) Galanthus nivalis agglutinin family, (7) proteins with hevein domains, (8) Jacalins, (9) proteins with legume lectin domains, (10) Lys motif domain, (11) Nictaba family (formerly Cucurbitaceae phloem lectins), and (12) Ricin-B family (Van Damme et al., 2008) . Among them, proteins with legume lectin domains have been the most extensively studied for their activities against different pathological diseases including cancer (Liu et al., 2010a) . Serial studies have shown that lectins possess mitogenic, antiproliferative, antitumor, antiviral, and immunestimulating potential. The chemopreventive activity reported from plant lectins using cell experiments and animal models as well as the mechanisms of action elucidated to date are summarized in Table 1 .
Lectins from mistletoe received more attention for their antiproliferative activities against multiple cancer cell lines. Firstly, lectins from European mistletoes were identified and studied, although subsequent analyses have demonstrated similar effects for Chinese and Korean mistletoes-derived lectins. Their sugar-binding capacity seems to play a crucial role in determining selective toxicity for cancer cells through interaction with sugar-chain or sugar-containing receptor present on the cell surface (Hoessli and Ahmad, 2008) . Accumulating evidence in the antiproliferative effects of mistletoe lectins towards various types of cancers such as human acute lymphoblastic and monoblastic leukemia (Pae et al., 2001; Fulda and Debatin, 2006; Hoessli and Ahmad, 2008; Seifert et al., 2008) , hepatocarcinoma (Lyu et al., 2002) , lung cancer A549 (Fulda and Debatin, 2006; Hoessli and Ahmad, 2008) , and colon cancer cells (Khil et al., 2007; Monira et al., 2009 ) are currently available. In addition to mistletoe, lectins are also present in other plant species. Concanavalin A is a lectin belonging to legume lectin family that was originally extracted from Canavalia ensiformes (jack-bean). It possesses a wide range of biological functions such as antitumor, antiviral, and antifungal activities (Fu et al., 2011) . As it has been reported for mistletoe lectins, the functions of concanavalin A have also been linked to its sugar-binding ability. Initially, this lectin was demonstrated to mediate cytotoxicity towards BALB/c 3T3 and gingival fibroblasts through apoptotic induction (Kulkarni and McCulloch, 1995) . As shown in Table 1 , the antiproliferative effects have also been observed against melanoma A375 and hepatocarcinoma HepG2 (Liu et al., 2009d (Liu et al., , 2010b , gliobastoma U87 (ProulxBonneau et al., 2010; Sina et al., 2010) , ovarian cancer SKOV3, and Li-Fraumeni syndrome MDAH041 cells (Amin et al., 2007) .
Although lectins derived from various plant sources have been demonstrated to exert chemopreventive effects against different cancer cell lines, only those derived from mistletoe and Arbus spp. have been assayed in animal models. First study showed that administration of Chinese mistletoe lectin delayed colon cancer development in a mice model through regulation of immune responses (Ma et al., 2008) . Li and coworkers also demonstrated the antineoplastic activity of mistletoe lectins in colorectal bearing mice . Intraperitoneal administration of mistletoe lectin preparations improved survival of mice injected with leukemia cells without any adverse side effects (Seifert et al., 2008) , and inhibited melanoma growth and its spread to the lung in a human melanoma cells xenograft mouse model (Thies et al., 2008) . In the case of Arbus, its derived-agglutinin has been shown to activate tumor-associated macrophages, to increase nitric oxide production, and to induce cytotoxicity against tumor cells in Dalton's lymphoma mouse model (Ghosh and Maiti, 2007) . Antitumor effects have also been observed in tumor-bearing mice after administration of lectin-derived peptide from Arbus through immunomodulatory actions (Bhutia et al., 2009) .
Considering the fact that plant lectins were initially described more than 30 years ago, their molecular mechanism of action is yet to be completely elucidated. Several mechanisms have been proposed, including effects on tumor cell membranes, ribosomes-binding ability, inhibitory activity of protein synthesis, cell cycle arresting ability, apoptotic induction through caspases-dependent and independent-pathways, autophagy stimulating effects, angiogenesis and metastasis inhibitory capacities, and immunomodulatory properties through inducting tumor-specific cytotoxicity of macrophages (de Mejia and Prisecaru, 2005; de Mejia and Dia, 2010; Fu et al., 2011; Liu et al., 2013) . Some of these plant proteins are currently being proven as therapeutic agents against cancer in human trials, holding considerable potential.
Protease inhibitors
Proteolysis, a tightly controlled process by enzymes, plays a crucial role in multiple physiological processes such as Dalton's lymphoma mice Activation of tumor-associated macrophages, increase of nitric oxide production, and increase of cytotoxicity towards tumor cells Ghosh and Maiti (2007) Lectin fertilization, homeostasis, neuronal development, apoptosis, and immunological responses (Safavi and Rostami, 2012) . The proteolytic enzymes constitute a protease family, whose components are classified in four major subcategories according to the interaction of protease catalytic residue with specific inhibitors. These categories are (1) serine proteases, (2) metalloproteases, (3) aspartic proteases, and (4) cysteine proteases. Proteases have been recognized as essential players in a wide range of physiological processes including cell cycle and signaling, digestion, immune response, blood coagulation, and wound healing. However, their deregulated proteolytic activity is linked to multiple human diseases, ranging from degenerative and inflammatory disorders to cancers (Clemente and Arqu es, 2014) . Thus, the activity of proteases requires to be tightly controlled through multiple pathways, such as modulation of enzyme expression and/or secretion, activation of inactive pro-enzymes (zymogens), pH regulation, and reversible/ irreversible inhibition (Debowski, 2013) .
Protease inhibitors are distributed into several families, including Bowman-Birk protease inhibitor (BBI), Kunitz-type protease inhibitor (KTI), serine protease inhibitor (serpin), squash inhibitory, potato I and II inhibitor, barley trypsin inhibitor, cysteine protease inhibitor (cystatin), and barley trypsin inhibitor families (Laskowski and Kato, 1980) . This section of the review focuses on the most studied protease inhibitors families, BBI and KTI families, present in legume seeds, whose chemopreventive properties have been evaluated by multiple in vitro and in vivo models.
The BBI family comprises polypeptides composed of less than 100 amino acids including 14 cysteine residues, and containing two inhibitory domains for trypsin and chymotrypsinlike enzymes. It has been demonstrated that BBI resists the acidic conditions and the action of proteolytic enzymes present in the gastrointestinal tract, allowing this polypeptide reaching the distal intestine in an intact and active form to exert its bioactive properties (Clemente et al., 2011) . Although BBI is ubiquitously distributed in the plant kingdom, the soybean BBI and BBI concentrate (BBIC) have received special attention because of their anti-inflammatory and chemopreventive activities against different types of cancer (Losso, 2008) . Evidence on the beneficial properties of BBI against cancer demonstrated by cell experiments and animal models as well as its potential modes of action are shown in Table 2 . Treatment with BBI has been reported to be effective in preventing chemical carcinogenesisinduced transformation in cultured mouse mammary glands (Du et al., 2001) . Moreover, BBI suppresses proliferation of human breast MCF-7 cells through reduction of proteasome function, resulting in upregulation of MAP kinase phosphatase-1, induction of apoptosis, and lysosome membrane permeabilization (Zheng et al., 1999; Chen et al., 2005; Ho and Ng, 2008) . BBI also possesses chemopreventive activity associated with induction of Cx43 expression and apoptosis in human prostate cancer LNCaP cells (Tang et al., 2009) , and in different prostate cancer animal models McCormick et al., 2007; Tang et al., 2009 ). The anticarcinogenic activities of BBI have also been shown in human osteosarcoma U2OS (Saito et al., 2007) , ovarian sarcoma M5067 (Sakurai et al, 2008a (Sakurai et al, , 2008b , hepatocarcinoma HepG2 (Ho and Ng, 2008) , and promyelocytic leukemia NB4 cells (Huang et al., 2007) . Recent studies have demonstrated a significant dose-and time-dependent decrease of colorectal human adenocarcinoma (HT29, Caco2, LoVo) cells proliferation after treatment with different BBI variants derived from pea (Clemente et al., 2005) , lentil (Caccialupi et al., 2010) , and soybean . However, BBI did not affect the growth of nonmalignant colonic fibroblastic CCD18-Co cells. In animal models, both BBI and BBIC have shown suppressive effects on carcinogen-induced transformation in the colon (Clemente and Arqu es, 2014) , oral cavity (Kennedy et al., 1993) , prostate , lung , and skin (Huang et al., 2004) .
In 1992, the Food and Drug Administration (FDA) approved the use of BBIC in clinical trials as a New Investigational Drug. Since then, different human trials have been completed in patients with benign prostatic hyperplasia (Malkowicz et al., 2001) , oral leukoplakia (Armstrong et al., 2000 (Armstrong et al., , 2003 Meyskens, 2001) , and ulcerative colitis (Lichtenstein et al., 2008) . Results from these studies indicated that BBI and BBIC are well tolerated, and no side effects have been associated with their use for a prolonged time.
KTI is another protease inhibitor originally isolated from soybean with trypsin inhibitory properties. Its ability to suppress invasion and metastasis of cancer cells has been demonstrated in several xenograft animal models after implantation of ovarian cancer HRA and Lewis lung carcinoma cells in C57BL/6 mice (Kobayashi et al., 2004a (Kobayashi et al., , 2004b . In addition, cell cultures have been carried out to elucidate the mechanism of action of this protease inhibitor. In lymphoma Nb2 cells, KTI caused decrease of cellular viability, apoptosis, DNA hypodiploidy, and fragmentation, without affecting normal lymphocytes (Troncoso et al., 2003) . KTI has also been shown to suppress urokinase-type plasminogen activator (uPA) signaling cascade and invasion in Y529F ovarian cancer cells (Inagaki et al., 2005) . Recently, a weak antiproliferative activity of Korean large black soybean-derived KTI has been revealed in nasopharyngeal cancer CNE-2 and HNE-2, breast cancer MCF-7, and hepatoma HepG2 cells . Similar results in MCF-7 and HepG2 cells were found after treatment with KTI isolated from seeds of small glossy black soybean (Ye and Ng, 2009 ). However, little information on the mechanisms of action of KTI is still available, and thus, further pharmacological, proteomic, and genetic approaches are required to allow its application in the future.
Lunasin
Lunasin is a 43-amino acid peptide identified in soybean 17 years ago (Galvez and de Lumen, 1999) and afterwards, in other seeds and legumes. A number of cell culture experiments and animal models have demonstrated the potent anticarcinogenic effect of this peptide in addition to its antioxidant and anti-inflammatory properties. All these effects have been summarized in Table 3 . Early studies demonstrated that lunasin neither affects morphology nor proliferation of noncancerigen mammalian cells. However, when a transformation event occurs, lunasin gets into action within the cell preventing induced-carcinogenic processes. Lunasin is capable to suppress transformation of chemical, and viral and ras-oncogenes-induced carcinogenesis in mammalian cells. Moreover, this peptide also exerts antineoplastic effects in established cancer cells-such as breast, colon, and prostateleukemia, and lymphoma cell lines through modulation of multiple cellular pathways implied in the initiation, promotion, and progression stages of cancer. Initially, the ability of lunasin to internalize into mammalian cells and sit within the nuclear compartment was highlighted (Galvez et al., 2001; Lam et al., 2003) . Beyond its internalization into the cell, biochemical evidence has shown that lunasin, either synthetic or extracted from natural plants, tends to bind to deacetylated core histones, and to inhibit core histones H3 and H4 acetylation. Moreover, this peptide acts in the presence of the histone deacetylase inhibitor sodium butyrate competing with different histone acetyltransferases (HAT) enzymes, such as PCAF, CBP/p300, and yGCN5 (Galvez et al., 2001; Jeong et al., 2002 Jeong et al., , 2003 Jeong et al., , 2007 . This evidence implied lunasin's role in chromatin remodeling, a process intimately related to the control of cell cycle progress and tumor progression (Esteller and Herman, 2002; Lund and van Lohuizen, 2004) , suggesting an epigenetic nature of the mechanisms of action of lunasin (Stefanska et al., 2012) . In addition, several studies on the lunasin's cancer-preventive effects have reported that this peptide is able to modulate expression of different genes and proteins involved in cell cycle, apoptosis, and signaling transduction as well as to act as antimetastatic agent (Table 3) . Recent animal studies have confirmed the properties of lunasin against different types of cancer, such as skin, breast, colon, and lymphoma. Hsieh and coworkers demonstrated that lunasin acts against breast cancer in both xenograft MDA-MB-231 and chemically induced breast cancer mice models (Hsieh et al., 2010a (Hsieh et al., , 2010b . Also, it has been reported that lunasin treatment delayed liver metastasis using colon cancer KM12L4 cells directly injected into athymic mice (Dia and de Mejia, 2011a) . A recent study has revealed that lunasin reduces tumor volume in the xenograft Raji mice lymphoma model (Chang et al., 2014) . The evidence makes lunasin as a promising candidate for a new generation of chemopreventive/chemotherapeutical agents derived from natural seeds. There is still much to learn about the effects of this peptide and its complete mechanisms of action, although this research area holds a huge potential.
Other chemopreventive plant derived proteins and peptides In the last years, the search of plant-derived proteins and/or peptides with anticancer properties has extended to multiple species. Hazelnuts, mainly used as ingredients for confectionary and for the production of hazelnut cream, have been recently found to contain proteins with potent antiproliferative activity against colon cancer CCC221/DLD-1 cells (Aydemir et al., 2014) . The protein isolate obtained from the Amaranthus mantegazzianus seed has shown antiproliferative effects, cell adhesion inhibitory and apoptosis inducing properties against the osteosarcoma UMR106 cell line, these effects being higher after the hydrolysis of seed proteins (Barrio and Añ on, 2010) . Hydrolysis of walnut proteins also allows liberating peptides with the antiproliferative action on human breast, colon, and cervical cancer cells without affecting the growth of normal epithelial cells (Zhai et al., 2013) . Similarly, trypsin has been used to hydrolyze the seed proteins of Polyalthia longifolia releasing peptides with cytotoxic activity against A549 and HeLa cells (Rupachandra and Sarada, 2013) . Canola or rapeseed production has increased rapidly over the past 40 years because of the importance of the canola oil that has become the third most produced vegetable oil worldwide (Alashi et al., 2013) . The remaining byproduct, known as canola seed meal, is used as a high protein animal feed (Aachary and Thiyam, 2012) . Also, its adequate balance of amino acids and its functional properties make canola meal an excellent supply of protein for human consumption. In addition, there is accumulated evidence on the relationship between canola proteins and health, which is due as a result of the presence of many peptides within the primary structure of proteins that once released, exert multiple beneficial properties, such as antihypertensive, antidiabetic, antioxidant, and anticancer properties (Aachary and Thiyam, 2012) . The antiproliferative and apoptotic inducing properties of rapeseed peptides have been recently demonstrated in human cervical cancer HeLa cells (Xue et al., 2011) . Treatment of cells with these peptides provoked morphology changes including cell shrinkage, nuclear fragmentation, and chromatin condensation, which are the typical characters of apoptotic cells.
Corn-derived peptides have shown to induce apoptosis and arrest cell cycle in hepatoma HepG2 cells, as well as to inhibit tumor growth and prolong survival of H22-bearing mice . However, the sequence of these peptides has not been elucidated yet. In other studies, some peptides have been characterized as being responsible for the observed effects. As an example, peptide ENPRP was identified in rice bran and characterized by its cell proliferative inhibitory properties against colon carcinoma Caco-2 and HCT-116, breast cancer MCF-7 and MDA-MB-231, and liver cancer HepG2 cells (Kannan et al., 2010) . Recently, it has been identified the peptide AWKLFDDGV in the seeds of Cycasrevoluta revolute with inhibitory properties of human epidermoid cancer Hep2 and colon carcinoma HCT15 cells proliferation (Mandal et al., 2012) .
Anticancer proteins and peptides from milk
Lactoferrin is a whey protein with multiple physiological activities such as antimicrobial and immunomodulatory properties that play a significant role in its chemopreventive effects (Kanwar and Kanwar, 2013) . Treatment of lactoferrin inhibited breast cancer MDA-MB-231 cells growth through arresting cell cycle at the G1/S transition (Damiens et al., 1999) . Additionally, lactoferrin induced growth arrest via nuclear accumulation of Smad-2 in HeLa cells (Zemann et al., 2010) , and suppressed AKT signaling in nasopharyngeal carcinoma cells (Deng et al., 2013) . In animal studies, oral administration of recombinant human lactoferrin significantly reduced head-and-neck squamous cell carcinoma in tumor-bearing mice. The possible mechanisms of action of this protein include the increase of interleukine (IL)-8 and activation of natural killer and CD8+ Tcells (Varadhachary et al., 2004) . Similarly, after oral administration of bovine lactoferrin to lung cancer transgenic mice, a significant suppression of tumor formation and reduction of tumor necrosis factor (TNF)-a, IL-4, IL-6, and IL-10 levels were observed (Tung et al., 2013) . In addition, bovine lactoferrin improved the chemotherapeutic effects of tamoxifen in the 4T1 breast cancer xenograft Balb/c mice model (Sun et al., 2012) .
Lactoferrin-derived peptide lactoferricin is one of the most studied anticancer peptides derived from milk. It has demonstrated potent activity against different types of cancer cell lines, including breast, colon, fibrosarcoma, leukemia, oral, and ovarian cancer cells, without harming normal lymphocytes, fibroblasts, endothelial, or epithelial cells (Furlong et al., 2010) . The strongly cationic character of this peptide that allows it to interact with negatively charged structures found in cancer cells seems to be responsible for its action (Hoskin and Ramamoorthy, 2008) . In addition to this mechanism, lactoferricin has been shown to arrest cell cycle, induce apoptosis, modulate gene expression, and prevent angiogenesis . In vivo evidence has revealed that subcutaneous treatment of lactoferrin in Meth A fibrosarcoma mice and neuroblastoma xenografts significantly inhibited tumor growth (Eliassen et al., 2002 (Eliassen et al., , 2006 . Similarly, administration of lactoferricin resulted in a significant inhibition of spontaneous melanoma cells growth, and suppression of lymphoma metastases in mouse liver and lung (Yoo et al., 1997) . Moreover, these authors demonstrated the capacity of this peptide to reduce the number of tumor-induced blood vessels inhibiting tumor angiogenesis.
Chemopreventive properties have also been demonstrated for whey protein a-lactalbumin combined with oleic acid. The complex formed with this protein from bovine origin and oleic acid, and known as Bovine Alpha-lactalbumin Made Lethal to Tumor cells or BAMLET, has been reported to induce cancer cell death (Pepe et al., 2013) . This complex acts through modulation of lysosomal membrane permeabilization and activation of the proapoptotic protein Bax (Svensson et al., 2003; Fast et al., 2005) . In addition, BAMLET causes chromatin condensation and cancer cells shrinkage. Human Alpha-lactalbumin Made Lethal to Tumor cells (HAMLET) has also been found to be cytotoxic against cancer cells. Treatment with HAMLET induced caspase activation and caused mitochondrial permeability resulting in a loss of mitochondrial membrane potential and cytochrome c release (Brinkmann et al., 2013) .
Recently, a whey-derived peptide mixture has been shown to induce apoptosis of human colon carcinoma HT-29 cells accompanied by induction of nuclear condensation, DNA fragmentation, and modulation of carcinogenesis biomarkers (Kreider et al., 2011) . However, to date, the responsible peptides for these effects have not been identified.
Casein has also been reported as a source of antiproliferative peptides. Among them, opioid casein-derived peptides, b-Casomorphin 7 and b-Casomorphin 5, have shown antiproliferative and cell cycle arresting activities in breast cancer cells that seem to be mediated through interaction with opioid receptors (Maneckjee et al., 1990; Hatzoglou et al., 1996) . Similarly, the interaction with specific opioid and somatostatin receptors present in the intestinal tract of mammals might be responsible for the antiproliferative effects on colon cancer cells treated with b-casomorphins and other milk-derived opioid peptides (Pepe et al., 2013) . Caseinophosphopeptides, through their ability to bind calcium and activate voltage-dependent calcium channels, seem to inhibit cellular proliferation and induce programmed cell death in intestinal tumor HT-29 and AZ-97 cells (Perego et al., 2012) .
Anticancer properties of egg proteins and peptides
Lysozyme is a bactericidal protein whose anticancer properties have been extensively studied. It was demonstrated that oral administration of this protein inhibited formation and growth of multiple tumors (Sava et al., 1991; Das et al., 1992; Pacor et al., 1999) . Moreover, this protein, administered to mice bearing B16 melanoma, significantly reduced the formation of spontaneous lung metastases and prolonged the survival after surgical removal of the primary tumor (Sava, 1989) . It has also been found as the ability of lysozyme to enhance the efficacy of chemotherapy treatments. Therefore, this protein is becoming a promising co-adjuvant therapy against cancer (Sava et al., 1995) .
Some studies have revealed the reduction of colorectal cancer in rats treated with hydrolyzates from egg yolk protein through inhibition of tumor cells proliferation (Azuma et al., 2000) . These protective effects might be due to the strong antioxidant properties of protein phosvitin and its derived-phospho-oligopeptides (Ishikawa et al., 2004) . Egg ovomucin has also been shown as a precursor of anticancer oligopeptides after the action of pronase because of the tumor growth inhibitory activity demonstrated for the hydrolyzate in a murine model (Watanabe et al., 1998) .
Antiproliferative peptides from marine organisms
Marine organisms, which make up approximately one half of the total worldwide biodiversity, contain multiple compounds with potential therapeutic applications (Kim and Wijesekara, 2010) . These compounds include phenols, alkaloids, terpenoids, polyesters, and other secondary metabolites, which are present in sponges, cyanobacteria, mollusks, and ascidians, among others (Jimeno et al., 2004) . Among them, an extensive group of peptides and depsipeptides with multiple biological activities have been extracted from different marine species. By modulating and improving physiological functions, these bioactive peptides may provide new therapeutic applications for the prevention and/or treatment of chronic diseases, such as cancer (Suarez-Jimenez et al., 2012) . Table 4 shows those marine organisms-derived peptides characterized by their anticancer activities as well as their mechanisms of action demonstrated by cell culture and animal models. Majority of peptides have been extracted from ascidians, mollusks, and sponges. As it is shown in Table 4 , sack-like sea squirts are an important source of potent anticancer peptides. Didemnins were firstly extracted from tunicate Trididemnum solidum, and then from other species of the same genus (Aneiros and Garateix, 2004) . Their preclinical evidence made these peptides the first marine natural products to be evaluated in clinical trials. However, phase II trials using Didemnin B at the recommended doses were inefficient, while using higher doses in trials resulted in high levels of toxicity, including cardiotoxicity (Shin et al., 1991) . Aplidine is a cyclodepsipeptide isolated from the tunicate Aplidium albicans, with potent properties against different cancer cell lines such as breast, melanoma, and lung cancer cells (Garc ıa-Fern andez et al., 2002) . The mechanism of action of this peptide includes cell proliferation inhibition, apoptosis induction, and cell cycle arrest. Early clinical phase I trials have revealed the efficacy of this peptide in humans, and phase II trials are currently ongoing. Other cyclic peptides with anticancer properties containing Tamandarins A and B were extracted from an unidentified Brazilian ascidian (Vervoort et al., 2000) , Mollamide from Didemnum molle (Carroll et al., 1994) , and Vitilevuamide from Didemnum cuculiferum and Polysyncranton lithostrotum (Edler et al., 2002) (Table 4) .
Mollusks include species with a wide range of pharmacological applications. Among the bioactive peptides identified in these species, Dolastatins, mainly Dolastatin 10 and 15, isolated from Dollabella auricularia, are the most promising reported to date (Pettit et al., 1995 (Pettit et al., , 1998 . Keenamide A is a cyclic hexapeptide isolated from the mollusk Pleurobranchus forskalii, which exhibits significant activity against the leukemia P388, lung cancer A549, melanoma MEL-20, and colon cancer HT-29 cells (Wesson and Hamann, 1996) . Kahalalide F is a dehydroaminobutyric acid-peptide that is known to exhibit interesting specific activity against prostate cancer cells. Also, the efficacy of this peptide demonstrated in phase I trials suggest its potential against other types of tumors, and currently, phase II trials are assaying the activity of Kahalalide F against lung and prostate cancer, and melanoma (Mart ın-Algarra et al., 2009).
Sponges are other important marine source of bioactive peptides, mostly cyclodepsipeptides, which are secondary metabolites with unusual amino acids and nonamino acid moieties. Jaspamide, a cyclic depsipeptide, was proven to inhibit cell proliferation and induce apoptosis in human promyelocytic leukemia HL-60 and Jurkat T cells (Odaka et al., 2000; Cioca and Kitano, 2002) . Arenastatin A is a cyclodepsipeptide isolated from Dysidia arenaria that has demonstrated a potent cytotoxicity against epidermal mouth carcinoma KB cells (Aneiros and Garateix, 2004) . Phakellistatins is a family of cyclic peptides identified in species from genus Phalkellia with proven activity against leukemia and liver cancer (Li et al., 2002) . Geodiamolide, Calyxamides A and B, and Milnamides F and G are examples of recently identified marine-derived peptides with anticancer properties mediated through multiple mechanisms (Freitas et al., 2008; Kimura et al., 2012; Tran et al., 2014) .
In recent years, there has been a great number of researches focused on the release of bioactive peptides encrypted within marine proteins after the action of proteolytic enzymes (Table 4) . Gelatin was obtained from the giant squid Dosidicus gigas that once hydrolyzed by Esperase enzyme showed high cytotoxic effect against human breast cancer MCF-7 and glioma U87 cells (Aleman et al., 2011 ). An oligopeptide-enriched hydrolyzate from oyster (Crassostrea gigas) has demonstrated to reduce tumor growth in a sarcoma S180-bearing BALB/C mice model . These authors also reported that the administration of this hydrolyzate significantly increased the weight of thymus and spleen, activity of natural killer cells, proliferation of splenocyte, and the phagocytic rate of macrophages. Also, recently, the anti-inflammatory properties of the oyster hydrolyzate have been demonstrated . This evidence suggests that the chemopreventive properties of this hydrolyzate may be attributed to its immunostimulating and anti-inflammatory activity. In some studies, the sequences of the peptides responsible for the observed effects have been elucidated. For example, the peptides LPHVLTPEAGAT and PTAEGGVYMVT contained in the hydrolyzate of tuna dark muscle have been recognized by their antiproliferative actions against breast cancer MCF-7 cells (Hsu et al., 2011) . Similarly, the cytotoxic activity of the hydrolyzate of shellfish Mytilus coruscus has been attributed to the peptide AFNIHNRNLL .
Bioactive peptides in functional foods: Future perspectives
With the rise of consumer preferences for natural components, food-derived bioactive substances with potential use as nutraceuticals have attracted the interest of researchers and industries. An extensive number of studies have focused on the identification and characterization of food-derived peptides and their potential application as ingredients of functional food promoting health and reducing the risk of chronic diseases, such as cancer. Nevertheless, most of the studies demonstrating the efficacy of food peptides as anticancer agents have been carried out using in vitro assays and/or in vivo systems. Data obtained from these studies are insufficient to demonstrate the effectiveness of peptides in humans, and to date, a limited number of clinical trials have been performed. The main limitations include obtaining and purifying sufficient quantity of bioactive peptide fractions to perform the human trial, as well as the challenge to identify the sequence responsible for the observed effects.
Application of separation protocols such as membrane processing and chromatographic isolation may also be an area of future interest in the extraction of potent bioactive peptides from natural foods, and their subsequent utilization as functional food ingredients. Additionally, these technologies can be used to fractionate protein hydrolyzates obtaining peptide fractions with higher potency (Barnes and Kim, 2004) . Membrane processing offers several advantages over conventional methods for separation, fractionation, and recovery of those bioactive components. Combination of membrane separation and supercritical fluid technologies would provide unique advantages resulting in a novel separation technology offering great potential for the nutraceuticals and functional foods industry (Akin et al., 2012) . Mass spectrometry techniques have become the main technology for the characterization of food proteins and peptides, playing a key role to understand their structure, nature, functional properties, and impact on human health (Mamone et al., 2009) .
Discrepancies among different human trials may also be caused by human diversity and phenotypic differences between individuals. In this context, advances in the field of genomics, proteomics, metabolomics, and transcriptomics are needed to benefit future clinical trials using food-derived proteins and peptides as new anticancer agents. Scientific progress must be based on a better understanding of how these food-derived peptides interact with the human body and can prevent the initiation, development, or progression of risk factors for cancer and/or other chronic diseases. 
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